Showing results (651-660 of 823) with videos related to

Sort By:
Pageof 83
International Journal of Molecular Sciences|January 27, 2024
Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote TumorigenesisJung-Yu Kan, Shen-Liang Shih, Sheau-Fang Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 31, 2017
TFG facilitates outer coat disassembly on COPII transport carriers to promote tethering and fusion with ER-Golgi intermediate compartmentsMichael G Hanna, Samuel Block, E B Frankel, et al.
Life Sciences|April 30, 2013
The synthetic flavonoid WYC02-9 inhibits colorectal cancer cell growth through ROS-mediated activation of MAPK14 pathwayYun-Ju Chen, Hsin-Pao Chen, Yu-Jen Cheng, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 31, 2007
[Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine]Jiang Fan, Jin-Song Lu, Wen-Jin Yin, et al.
Molecules (Basel, Switzerland)|July 11, 2018
Correction: Huang, H.W.; et al. Sinularin Selectively Kills Breast Cancer Cells Showing G2/M Arrest, Apoptosis, and Oxidative DNA Damage. Molecules 2018, 23, 849Hurng-Wern Huang, Jen-Yang Tang, Fu Ou-Yang, et al.
International Journal of Colorectal Disease|September 11, 2012
Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resectionHsiang-Lin Tsai, I-Ping Yang, Chih-Hung Lin, et al.
Acta Crystallographica. Section D, Biological Crystallography|June 11, 2014
L-allo-threonine aldolase with an H128Y/S292R mutation from Aeromonas jandaei DK-39 reveals the structural basis of changes in substrate stereoselectivityHui-Min Qin, Fabiana Lica Imai, Takuya Miyakawa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 31, 2023
Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancerCheng-Che Wu, Mei-Ren Pan, Shen-Liang Shih, et al.
Pharmacogenetics and Genomics|November 9, 2010
Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapyMing-Yii Huang, Meng-Lin Huang, Ming-Jenn Chen, et al.
Asia-Pacific Journal of Clinical Oncology|October 19, 2017
Efficacy and toxicity of pegylated liposomal doxorubicin-based chemotherapy in early-stage breast cancer: a multicenter retrospective case-control studyFu Ou Yang, Nicholas C Hsu, Sin-Hua Moi, et al.
Pageof 83